Homoharringtonine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of telomerase

American Journal of Chinese Medicine

Volumn 34, Issue 2, 2006, Pages 233-244

  Xie, Wan Zhuo ^a   Lin, Mao Fang ^a   Huang, He ^a   Cai, Zhen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Homoharringtonine; Leukemia cell; Telomerase

Indexed keywords

DNA; HOMOHARRINGTONINE; TELOMERASE;

ACUTE GRANULOCYTIC LEUKEMIA; AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DESIGN; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NICK END LABELING; PROTEIN CONTENT; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

APOPTOSIS; DOWN-REGULATION; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HARRINGTONINES; HL-60 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON, TRANSMISSION; TELOMERASE;

EID: 33645059439     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X06003795     Document Type: Article

References (30)

1. Akiyama, M., J. Horiguchi-Yamada, S. Saito, Y. Hoshi, O. Yamada, H. Mizoguchi and H. Yamada. Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro. Eur. J. Cancer 35: 309-315, 1999.
2. Blackburn, E. and C. Greider (eds.). Telomeres. Cold Spring Harbor Laboratory Press, New York, 1995.
3. Cai, Z., M. Lin, C. Wuchter, V. Ruppert, B. Dörken, W.D. Ludwig and L. Karawajew. Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation. Leukemia 15: 567-574, 2001.
4. Choi, S.H., S.Y. Lyu and W.B. Park. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt. Arch Pharm Res. 27: 68-76, 2004.
5. Coonley, C.J., R.P. Warrell and C.W. Young. Phase I trial of homoharringtonine administered as a 5-day continuous infusion. Cancer Treat Rep. 67: 693-696, 1983.
6. Cortes, J. and H. Kantarjian. Advanced-phase chronic myeloid leukemia. Semin. Hematol. 40: 79-86, 2003.
7. Counter, C.M., A.A. Avilion, C.E. Lefeuvre, N.G. Stewart, C.W. Greider, C.B. Harley and S. Bacchetti. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11: 1921-1929, 1992.
8. de Lange, T. and T. Jacks. For better or worse? Telomerase inhibition and cancer. Cell 98: 273-275, 1999.
9. Engelhardt, M., K. Mackenzie, P. Drullinsky, R.T. Silver and M.A. Moore. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res. 60: 610-617, 2000.
10. Fu, W., J.G. Begley, M.W. Killen and M.P. Mattson. Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274: 7264-7271, 1999.
11. Giridharan, P., S.T. Somasundaram, K. Perumal, R.A. Vishwakarma, N.P. Karthikeyan, R. Velmurugan and A. Balakrishnan. Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis. Br. J. Cancer 87: 98-105, 2002.
12. Gorbunova, V. and A. Seluanov. Telomerase as a growth-promoting factor. Cell Cycle 2: 534-547, 2003.
13. Harley, C.B., A.B. Futcher and C.W. Greider. Telomeres shorten during aging of human fibroblasts. Nature 345: 458-460, 1990.
14. Herrmann, M., H.M. Lorenz, R. Voll, M. Grunke, W. Woith and J.R. Kalden. A rapid and simple method for the isolation of apoptotic DNA fragnients. Nucleic Acids Res. 22: 5506-5507, 1994.
15. Holt, S.E., V.V. Glinsky, A.B. Ivanova and G.V. Glinsky. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol. Carcinog. 25: 241-248, 1999a.
16. Holt, S.E. and J.W. Shay. Role of telomerase in cellular proliferation and cancer. J. Cell Physiol. 180: 10-18, 1999b.
17. Kantarjian, H.M., M. Talpaz, V. Santini, A. Murgo, B. Cheson and S.M. O'Brien. Homoharringtonine: History, current research, and future direction. Cancer 92: 1591-1605, 2001.
18. Kim, N.W, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich and J.W. Shay. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
19. Komata, T., Y. Kondo, T. Kanzawa, H. Ito, S. Hirohata, S. Koga, H. Sumiyoshi, M. Takakura, M. Inoue, B.P. Barna, I.M. Germano, S. Kyo and S. Kondo. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells. Hum. Gene Ther. 13: 1015-1025, 2002.
20. Kondo, S., B.P. Barna, T. Morimura, J. Takeuchi, J. Yuan, A. Akbasak and G.H. Barnett. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res. 55: 6166-6171, 1995.
21. Kondo, Y., S. Kondo, Y. Tanaka, T. Haqqi, B.P. Barna and J.K. Cowell. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16: 2243-2248, 1998.
22. Mandal, M. and R. Kumar. Bcl-2 modulates telomerase activity. J. Biol. Chem. 272: 14183-14187, 1997.
23. Ni, D., D.H. Ho, M. Vijjeswarapu, E. Felix, P.R. Rhea and Newman R.A. Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia. J. Exp. Ther. Oncol. 3: 47-52, 2003.
24. Ohshima, K., K. Karube, K. Shimazaki, H. Kamma, J. Suzumiya, M. Hamasaki and M. Kikuchi. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: Possible role in ineffective hemopoiesis. Leuk. Lymphoma 44: 1339-1346, 2003.
25. Ohyashiki, J.H., K. Ohyashiki, H. Iwama, S. Hayashi, K. Toyama and J.W. Shay. Clinical implications of telomerase activity levels in acute leukemia. Clin. Cancer Res. 3: 619-625, 1997.
26. Robertson, D. Cancer researchers validate and pursue telomerase. Nat. Biotechnol. 15: 518, 1997.
27. Roth, A., S. Vercauteren, H.J. Sutherland and P.M. Lansdorp. Telomerase is limiting the growth of acute myeloid leukemia cells. Leukemia 17: 2410-2417, 2003.
28. Seol, J.G., E.S. Kim, W.H. Park, C.W. Jung, B.K. Kim and Y.Y. Lee. Telomerase activity in acute myelogenous leukaemia: Clinical and biological implications. Br. J. Haematol. 100: 156-165, 1998.
29. Skladanowski, A. and J. Konopa. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem. Pharmacol. 46: 375-382, 1993.
30. van Steensel, B., A. Smogorzewska and T. de Lange. TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413, 1998.